Cosmos Health Retires $8M Convertible Note Early, Eliminating Dilution Overhang
COSM sits 44% above its 52-week low of $0.162 on light trading volume (0.1× avg).
Summary
Cosmos Health retired its $8M senior secured convertible note to ATW a full year ahead of its August 2027 maturity, removing a major source of dilution and cutting annual interest costs. The company also withdrew its S-1 and S-3 registration statements, leaving no active shelf or ATM program, and confirmed no structured or floorless variable-rate instruments remain. This follows a period of heavy dilution from note conversions and a going concern warning in the latest 10-Q, so the deleveraging and simplified capital structure mark a meaningful shift. Management says operating cash burn fell over 30% in H1 2026 versus the prior two-year average, and Bitcoin holdings are now in a gain position. The next warrant tranche carries a $0.95 exercise price, well above the current $0.23 share price, reducing near-term overhang. The company continues its $5M buyback program, which could further support the stock.
At the time of this announcement, COSM was trading at $0.23 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $23.5M. The 52-week trading range was $0.16 to $1.32. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.